BNP Paribas Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.76M Buy
327,009
+80,158
+32% +$1.61M 0.01% 824
2025
Q4
$4.88M Buy
246,851
+245,379
+16,670% +$4.41M 0.01% 851
2025
Q3
$26K Buy
1,472
+356
+32% +$5.28K ﹤0.01% 1286
2025
Q2
$16K Buy
+1,116
New +$18K ﹤0.01% 1588

Other funds holding ALHC

BNP Paribas Asset Management's ALHC Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Alignment Healthcare (ALHC) stake by 32% in Q1 2026, buying an estimated $1.61M and bringing the position to 327,009 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #824.

BNP Paribas Asset Management first reported a position in ALHC in Q2 2025 and has held it in 4 quarters since. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • BNP Paribas Asset Management held 327,009 shares of Alignment Healthcare worth $5.76M as of Q1 2026.
  • BNP Paribas Asset Management bought 80,158 Alignment Healthcare shares in Q1 2026, an estimated $1.61M.
  • Alignment Healthcare made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #824 holding.
  • BNP Paribas Asset Management first reported a position in Alignment Healthcare in Q2 2025 and has held it in 4 quarters since.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.